SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 139 filers reported holding SERES THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.85 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $128,385 | -40.7% | 53,943 | +19.3% | 0.00% | – |
| Q2 2023 | $216,532 | +2.7% | 45,205 | +21.5% | 0.00% | – |
| Q1 2023 | $210,878 | -9.6% | 37,192 | -10.7% | 0.00% | – |
| Q4 2022 | $233,256 | +74.1% | 41,653 | +99.5% | 0.00% | – |
| Q3 2022 | $134,000 | +83.6% | 20,882 | -1.7% | 0.00% | – |
| Q2 2022 | $73,000 | -55.5% | 21,243 | -7.9% | 0.00% | – |
| Q1 2022 | $164,000 | -13.2% | 23,057 | +1.4% | 0.00% | – |
| Q4 2021 | $189,000 | -17.8% | 22,742 | -31.4% | 0.00% | – |
| Q3 2021 | $230,000 | -83.2% | 33,140 | -42.4% | 0.00% | -100.0% |
| Q2 2021 | $1,371,000 | +13.6% | 57,519 | -1.8% | 0.00% | 0.0% |
| Q1 2021 | $1,207,000 | +51.8% | 58,583 | +80.7% | 0.00% | 0.0% |
| Q4 2020 | $795,000 | +250.2% | 32,424 | +304.7% | 0.00% | – |
| Q3 2020 | $227,000 | – | 8,012 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 21,571,764 | $610,696,000 | 16.87% |
| RA Capital Management | 4,750,000 | $134,473,000 | 2.46% |
| ARK Investment Management | 12,293,033 | $348,016,000 | 2.06% |
| Opaleye Management Inc. | 335,312 | $9,493,000 | 1.86% |
| Sio Capital Management, LLC | 316,800 | $8,969,000 | 1.78% |
| Ikarian Capital, LLC | 762,400 | $21,585,000 | 1.56% |
| Nikko Asset Management Americas, Inc. | 5,531,670 | $152,176,000 | 1.35% |
| EAM Global Investors LLC | 121,629 | $3,443,000 | 1.26% |
| EAM Investors, LLC | 133,591 | $3,782,000 | 0.90% |
| GILDER GAGNON HOWE & CO LLC | 3,185,420 | $90,179,000 | 0.56% |